■ Carl Zeiss Meditec has become a shareholder of MicroOptx Inc., a privately held company focused on innovative minimally invasive glaucoma surgery (MIGS) devices for treatment of glaucoma. Its surgical technology is designed to provide effective reduction of IOP with a simple procedure. Zeiss says it is demonstrating its support for breakthrough surgical treatments for glaucoma and believes MicroOptx’s MIGS solution will complement its portfolio of equipment and consumables in ophthalmic surgery.